Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 293

1.

Drivers of the relative richness of naturalized and invasive plant species on Earth.

Essl F, Dawson W, Kreft H, Pergl J, Pyšek P, Van Kleunen M, Weigelt P, Mang T, Dullinger S, Lenzner B, Moser D, Maurel N, Seebens H, Stein A, Weber E, Chatelain C, Inderjit, Genovesi P, Kartesz J, Morozova O, Nishino M, Nowak PM, Pagad S, Shu WS, Winter M.

AoB Plants. 2019 Sep 4;11(5):plz051. doi: 10.1093/aobpla/plz051. eCollection 2019 Oct.

2.

FLOTROP, a massive contribution to plant diversity data for open ecosystems in northern tropical Africa.

Taugourdeau S, Daget P, Chatelain C, Mathieu D, Juanes X, Huguenin J, Ickowicz A.

Sci Data. 2019 Jul 8;6(1):118. doi: 10.1038/s41597-019-0120-8.

3.

Prospective and comparative study of paroxysmal nocturnal hemoglobinuria patients treated or not by eculizumab: Focus on platelet extracellular vesicles.

Devalet B, Wannez A, Bailly N, Alpan L, Gheldof D, Douxfils J, Bihin B, Chatelain B, Dogné JM, Chatelain C, Mullier F.

Medicine (Baltimore). 2019 Jul;98(27):e16164. doi: 10.1097/MD.0000000000016164.

4.

Extracellular Vesicles in Red Blood Cell Concentrates: An Overview.

Wannez A, Devalet B, Chatelain B, Chatelain C, Dogné JM, Mullier F.

Transfus Med Rev. 2019 Apr;33(2):125-130. doi: 10.1016/j.tmrv.2019.02.002. Epub 2019 Feb 23. Review.

PMID:
30910256
5.

The Global Naturalized Alien Flora (GloNAF) database.

van Kleunen M, Pyšek P, Dawson W, Essl F, Kreft H, Pergl J, Weigelt P, Stein A, Dullinger S, König C, Lenzner B, Maurel N, Moser D, Seebens H, Kartesz J, Nishino M, Aleksanyan A, Ansong M, Antonova LA, Barcelona JF, Breckle SW, Brundu G, Cabezas FJ, Cárdenas D, Cárdenas-Toro J, Castaño N, Chacón E, Chatelain C, Conn B, de Sá Dechoum M, Dufour-Dror JM, Ebel AL, Figueiredo E, Fragman-Sapir O, Fuentes N, Groom QJ, Henderson L, Inderjit, Jogan N, Krestov P, Kupriyanov A, Masciadri S, Meerman J, Morozova O, Nickrent D, Nowak A, Patzelt A, Pelser PB, Shu WS, Thomas J, Uludag A, Velayos M, Verkhosina A, Villaseñor JL, Weber E, Wieringa JJ, Yazlık A, Zeddam A, Zykova E, Winter M.

Ecology. 2019 Jan;100(1):e02542. doi: 10.1002/ecy.2542. Epub 2018 Dec 5.

PMID:
30341991
6.

Diagnosis and management of PNH: Review and recommendations from a Belgian expert panel.

Devos T, Meers S, Boeckx N, Gothot A, Deeren D, Chatelain B, Chatelain C, Devalet B.

Eur J Haematol. 2018 Dec;101(6):737-749. doi: 10.1111/ejh.13166. Epub 2018 Oct 23. Review.

PMID:
30171728
7.

Circulating MicroRNAs as Biomarkers in Diffuse Large B-cell Lymphoma: A Pilot Prospective Longitudinal Clinical Study.

Bouvy C, Wannez A, George F, Graux C, Chatelain C, Dogné JM.

Biomark Cancer. 2018 Jun 18;10:1179299X18781095. doi: 10.1177/1179299X18781095. eCollection 2018.

8.

Performance of epistasis detection methods in semi-simulated GWAS.

Chatelain C, Durand G, Thuillier V, Augé F.

BMC Bioinformatics. 2018 Jun 18;19(1):231. doi: 10.1186/s12859-018-2229-8.

9.

BCR-ABL Tyrosine Kinase Inhibitors: Which Mechanism(s) May Explain the Risk of Thrombosis?

Haguet H, Douxfils J, Chatelain C, Graux C, Mullier F, Dogné JM.

TH Open. 2018 Feb 14;2(1):e68-e88. doi: 10.1055/s-0038-1624566. eCollection 2018 Jan. Review.

10.

Transfer of multidrug resistance among acute myeloid leukemia cells via extracellular vesicles and their microRNA cargo.

Bouvy C, Wannez A, Laloy J, Chatelain C, Dogné JM.

Leuk Res. 2017 Nov;62:70-76. doi: 10.1016/j.leukres.2017.09.014. Epub 2017 Sep 25.

PMID:
28987820
11.

Eculizumab decreases the procoagulant activity of extracellular vesicles in paroxysmal nocturnal hemoglobinuria: A pilot prospective longitudinal clinical study.

Wannez A, Devalet B, Bouvy C, Laloy J, Bihin B, Chatelain B, Chatelain C, Dogné JM, Mullier F.

Thromb Res. 2017 Aug;156:142-148. doi: 10.1016/j.thromres.2017.06.013. Epub 2017 Jun 9.

PMID:
28646725
12.

Spotting L3 slice in CT scans using deep convolutional network and transfer learning.

Belharbi S, Chatelain C, Hérault R, Adam S, Thureau S, Chastan M, Modzelewski R.

Comput Biol Med. 2017 Aug 1;87:95-103. doi: 10.1016/j.compbiomed.2017.05.018. Epub 2017 May 19.

PMID:
28558319
13.

Application of a clot-based assay to measure the procoagulant activity of stored allogeneic red blood cell concentrates.

Devalet B, Wannez A, Bailly N, Alpan L, Gheldof D, Douxfils J, Deneys V, Bihin B, Chatelain B, Dogné JM, Chatelain C, Mullier F.

Blood Transfus. 2018 Feb;16(2):163-172. doi: 10.2450/2017.0230-16. Epub 2017 Mar 9.

14.

Proteomic and transcriptomic study of brain microvessels in neonatal and adult mice.

Porte B, Chatelain C, Hardouin J, Derambure C, Zerdoumi Y, Hauchecorne M, Dupré N, Bekri S, Gonzalez B, Marret S, Cosette P, Leroux P.

PLoS One. 2017 Jan 31;12(1):e0171048. doi: 10.1371/journal.pone.0171048. eCollection 2017.

15.

Procoagulant activity of extracellular vesicles as a potential biomarker for risk of thrombosis and DIC in patients with acute leukaemia.

Gheldof D, Haguet H, Dogné JM, Bouvy C, Graux C, George F, Sonet A, Chatelain C, Chatelain B, Mullier F.

J Thromb Thrombolysis. 2017 Feb;43(2):224-232. doi: 10.1007/s11239-016-1471-z.

PMID:
28074413
16.

Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis.

Haguet H, Douxfils J, Mullier F, Chatelain C, Graux C, Dogné JM.

Expert Opin Drug Saf. 2017 Jan;16(1):5-12. Epub 2016 Nov 28. Review.

PMID:
27852118
17.

Association Between BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia and Cardiovascular Events, Major Molecular Response, and Overall Survival: A Systematic Review and Meta-analysis.

Douxfils J, Haguet H, Mullier F, Chatelain C, Graux C, Dogné JM.

JAMA Oncol. 2016 May 1;2(5):625-632. doi: 10.1001/jamaoncol.2015.5932.

PMID:
26847662
18.

Edoxaban: Impact on routine and specific coagulation assays. A practical laboratory guide.

Douxfils J, Chatelain B, Chatelain C, Dogné JM, Mullier F.

Thromb Haemost. 2016 Jan;115(2):368-81. doi: 10.1160/TH15-05-0415. Epub 2015 Oct 29.

PMID:
26510969
19.

Global exchange and accumulation of non-native plants.

van Kleunen M, Dawson W, Essl F, Pergl J, Winter M, Weber E, Kreft H, Weigelt P, Kartesz J, Nishino M, Antonova LA, Barcelona JF, Cabezas FJ, Cárdenas D, Cárdenas-Toro J, Castaño N, Chacón E, Chatelain C, Ebel AL, Figueiredo E, Fuentes N, Groom QJ, Henderson L, Inderjit, Kupriyanov A, Masciadri S, Meerman J, Morozova O, Moser D, Nickrent DL, Patzelt A, Pelser PB, Baptiste MP, Poopath M, Schulze M, Seebens H, Shu WS, Thomas J, Velayos M, Wieringa JJ, Pyšek P.

Nature. 2015 Sep 3;525(7567):100-3. doi: 10.1038/nature14910. Epub 2015 Aug 19.

PMID:
26287466
20.

Pathophysiology, diagnosis, and treatment of paroxysmal nocturnal hemoglobinuria: a review.

Devalet B, Mullier F, Chatelain B, Dogné JM, Chatelain C.

Eur J Haematol. 2015 Sep;95(3):190-8. doi: 10.1111/ejh.12543. Epub 2015 Mar 26. Review.

PMID:
25753400
21.

Beamlet based direct aperture optimization for MERT using a photon MLC.

Henzen D, Manser P, Frei D, Volken W, Neuenschwander H, Born EJ, Joosten A, Lössl K, Aebersold DM, Chatelain C, Stampanoni MF, Fix MK.

Med Phys. 2014 Dec;41(12):121711. doi: 10.1118/1.4901638.

PMID:
25471958
22.

Myelofibrosis patients in Belgium: disease characteristics.

Devos T, Zachée P, Bron D, Noens L, Droogenbroeck JV, Mineur P, Beguin Y, Berneman Z, Benghiat FS, Kentos A, Chatelain C, Demuynck H, Lemmens J, Eygen KV, Theunissen K, Trullemans F, Pierre P, Pluymers W, Knoops L.

Acta Clin Belg. 2015 Apr;70(2):105-11. doi: 10.1179/2295333714Y.0000000097. Epub 2014 Nov 6.

23.

Contributing role of extracellular vesicles on vascular endothelium haemostatic balance in cancer.

Bouvy C, Gheldof D, Chatelain C, Mullier F, Dogné JM.

J Extracell Vesicles. 2014 Jul 11;3. doi: 10.3402/jev.v3.24400. eCollection 2014. Review.

24.

Appropriateness of prescribing dabigatran etexilate and rivaroxaban in patients with nonvalvular atrial fibrillation: a prospective study.

Larock AS, Mullier F, Sennesael AL, Douxfils J, Devalet B, Chatelain C, Dogné JM, Spinewine A.

Ann Pharmacother. 2014 Oct;48(10):1258-68. doi: 10.1177/1060028014540868. Epub 2014 Jun 30.

PMID:
24982310
25.

Patterns in melanocytic lesions: impact of the geometry on growth and transport inside the epidermis.

Balois T, Chatelain C, Ben Amar M.

J R Soc Interface. 2014 Aug 6;11(97):20140339. doi: 10.1098/rsif.2014.0339.

26.

Microparticle-associated tissue factor activity and overt disseminated intravascular coagulation in patients with acute myelocytic leukemia.

Gheldof D, Chatelain C, Dogné JM, Mullier F.

Thromb Res. 2014 Jul;134(1):213-4. doi: 10.1016/j.thromres.2014.05.001. Epub 2014 May 10. No abstract available.

PMID:
24861693
27.

Griffiths phase and critical behavior of the two-dimensional Potts models with long-range correlated disorder.

Chatelain C.

Phys Rev E Stat Nonlin Soft Matter Phys. 2014 Mar;89(3):032105. Epub 2014 Mar 10.

PMID:
24730788
28.

The central role of extracellular vesicles in the mechanisms of thrombosis in paroxysmal nocturnal haemoglobinuria: a review.

Devalet B, Mullier F, Chatelain B, Dogné JM, Chatelain C.

J Extracell Vesicles. 2014 Mar 24;3. doi: 10.3402/jev.v3.23304. eCollection 2014. Review.

29.

[Why, when and how to monitor new oral anticoagulants].

Tamigniau A, Douxfils J, Nicolas JB, Devalet B, Larock AS, Spinewine A, Dincq AS, Lessire S, Gourdin M, Watelet JB, Mathieux V, Chatelain C, Dogné JM, Chatelain B, Mullier F.

Rev Med Suisse. 2014 Feb 5;10(416):326-33. French.

PMID:
24624625
30.

Monte Carlo based beam model using a photon MLC for modulated electron radiotherapy.

Henzen D, Manser P, Frei D, Volken W, Neuenschwander H, Born EJ, Vetterli D, Chatelain C, Stampanoni MF, Fix MK.

Med Phys. 2014 Feb;41(2):021714. doi: 10.1118/1.4861711.

PMID:
24506605
31.

Platelet microparticle generation assay: a valuable test for immune heparin-induced thrombocytopenia diagnosis.

Mullier F, Minet V, Bailly N, Devalet B, Douxfils J, Chatelain C, Elalamy I, Dogné JM, Chatelain B.

Thromb Res. 2014 Jun;133(6):1068-73. doi: 10.1016/j.thromres.2013.12.009. Epub 2013 Dec 9.

PMID:
24360929
32.

Microparticle bearing tissue factor: a link between promyelocytic cells and hypercoagulable state.

Gheldof D, Mullier F, Bailly N, Devalet B, Dogné JM, Chatelain B, Chatelain C.

Thromb Res. 2014 Mar;133(3):433-9. doi: 10.1016/j.thromres.2013.11.008. Epub 2013 Nov 16.

PMID:
24290525
33.

Comparison of five D-dimer reagents and application of an age-adjusted cut-off for the diagnosis of venous thromboembolism in emergency department.

Mullier F, Vanpee D, Jamart J, Dubuc E, Bailly N, Douxfils J, Chatelain C, Dogné JM, Chatelain B.

Blood Coagul Fibrinolysis. 2014 Jun;25(4):309-15. doi: 10.1097/MBC.0000000000000020.

PMID:
24247319
34.

Characterisation of tissue factor-bearing extracellular vesicles with AFM: comparison of air-tapping-mode AFM and liquid Peak Force AFM.

Hardij J, Cecchet F, Berquand A, Gheldof D, Chatelain C, Mullier F, Chatelain B, Dogné JM.

J Extracell Vesicles. 2013 Aug 27;2. doi: 10.3402/jev.v2i0.21045. eCollection 2013.

35.

Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban.

Douxfils J, Tamigniau A, Chatelain B, Chatelain C, Wallemacq P, Dogné JM, Mullier F.

Thromb Haemost. 2013 Oct;110(4):723-31. doi: 10.1160/TH13-04-0274. Epub 2013 Jul 11.

PMID:
23846172
36.

Inhibition of tissue factor pathway inhibitor increases the sensitivity of thrombin generation assay to procoagulant microvesicles.

Gheldof D, Mullier F, Chatelain B, Dogné JM, Chatelain C.

Blood Coagul Fibrinolysis. 2013 Jul;24(5):567-72. doi: 10.1097/MBC.0b013e328360a56e.

PMID:
23807485
37.

Assessment of the performances of AcuStar HIT and the combination with heparin-induced multiple electrode aggregometry: a retrospective study.

Minet V, Bailly N, Douxfils J, Osselaer JC, Laloy J, Chatelain C, Elalamy I, Chatelain B, Dogné JM, Mullier F.

Thromb Res. 2013 Sep;132(3):352-9. doi: 10.1016/j.thromres.2013.06.004. Epub 2013 Jun 23.

PMID:
23803389
38.

Impact of apixaban on routine and specific coagulation assays: a practical laboratory guide.

Douxfils J, Chatelain C, Chatelain B, Dogné JM, Mullier F.

Thromb Haemost. 2013 Aug;110(2):283-94. doi: 10.1160/TH12-12-0898. Epub 2013 Jun 13.

PMID:
23765180
39.

Dosimetric properties of an amorphous silicon EPID for verification of modulated electron radiotherapy.

Chatelain C, Vetterli D, Henzen D, Favre P, Morf D, Scheib S, Fix MK, Manser P.

Med Phys. 2013 Jun;40(6):061710. doi: 10.1118/1.4805113.

PMID:
23718589
40.

A DNA metabarcoding study of a primate dietary diversity and plasticity across its entire fragmented range.

Quéméré E, Hibert F, Miquel C, Lhuillier E, Rasolondraibe E, Champeau J, Rabarivola C, Nusbaumer L, Chatelain C, Gautier L, Ranirison P, Crouau-Roy B, Taberlet P, Chikhi L.

PLoS One. 2013;8(3):e58971. doi: 10.1371/journal.pone.0058971. Epub 2013 Mar 19.

41.

Pre-analytical issues in the measurement of circulating microparticles: current recommendations and pending questions.

Mullier F, Bailly N, Chatelain C, Chatelain B, Dogné JM.

J Thromb Haemost. 2013 Apr;11(4):693-6. doi: 10.1111/jth.12171. No abstract available.

42.

Assessment of the impact of rivaroxaban on coagulation assays: laboratory recommendations for the monitoring of rivaroxaban and review of the literature.

Douxfils J, Mullier F, Loosen C, Chatelain C, Chatelain B, Dogné JM.

Thromb Res. 2012 Dec;130(6):956-66. doi: 10.1016/j.thromres.2012.09.004. Epub 2012 Sep 21. Review.

PMID:
23006523
43.

Anatomical study of secondary tuberized roots of Harpagophytum procumbens DC and quantification of harpagoside by high-performance liquid chromatography method.

Babili FE, Fouraste I, Rougaignon C, Moulis C, Chatelain C.

Pharmacogn Mag. 2012 Apr;8(30):175-80. doi: 10.4103/0973-1296.96587.

44.

Velamo do campo: its volatile constituents, secretory elements, and biological activity.

El Babili F, Roques C, Haddioui L, Bellvert F, Bertrand C, Chatelain C.

J Med Food. 2012 Jul;15(7):671-6. doi: 10.1089/jmf.2011.0252. Epub 2012 May 21.

PMID:
22612296
45.

A case of therapy-related myeloid neoplasm in a patient with Crohn's disease treated with azathioprine.

Mullier F, Rahier JF, Maignen F, Cornet Y, Graux C, Chatelain C, Chatelain B, Dogne JM.

Acta Haematol. 2012;128(1):1-6. doi: 10.1159/000337046. Epub 2012 May 4. Review.

PMID:
22572218
46.

[Clinical studies, the interests and limits of using dabigatran in atrial fibrillation].

Sternotte A, Douxfils J, Chatelain B, Chatelain C, Mullier F, Dogné JM, Spinewine A.

J Pharm Belg. 2012 Mar;(1):8-17. Review. French.

PMID:
22536678
47.

Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate.

Douxfils J, Mullier F, Robert S, Chatelain C, Chatelain B, Dogné JM.

Thromb Haemost. 2012 May;107(5):985-97. doi: 10.1160/TH11-11-0804. Epub 2012 Mar 22.

PMID:
22438031
48.

Radiation-induced double strand breaks and subsequent apoptotic DNA fragmentation in human peripheral blood mononuclear cells.

Ghardi M, Moreels M, Chatelain B, Chatelain C, Baatout S.

Int J Mol Med. 2012 May;29(5):769-80. doi: 10.3892/ijmm.2012.907. Epub 2012 Feb 7.

PMID:
22322361
49.

Morphological changes in early melanoma development: influence of nutrients, growth inhibitors and cell-adhesion mechanisms.

Chatelain C, Ciarletta P, Ben Amar M.

J Theor Biol. 2011 Dec 7;290:46-59. doi: 10.1016/j.jtbi.2011.08.029. Epub 2011 Sep 1.

PMID:
21903099
50.

Morphology, cytogenetics, and survival in myelodysplasia with del(20q) or ider(20q): a multicenter study.

Mullier F, Daliphard S, Garand R, Dekeyser M, Cornet Y, Luquet I, Talmant P, Richebourg S, Jamar M, Dogné JM, Chatelain C, Michaux L, Chatelain B.

Ann Hematol. 2012 Feb;91(2):203-13. doi: 10.1007/s00277-011-1286-0. Epub 2011 Jul 9.

PMID:
21744002

Supplemental Content

Loading ...
Support Center